Hi all!
Currently a first-year analyst in the Portfolio Valuation team for one of the largest HFs/PEs in the world. Have experience working with OPM, Multiples Analysis, Transaction Comps, and DCFs across the TMT and Healthcare space as well as running management calls and internal valuation committee meetings. With that being said, I am looking to change the pace and potentially pivot into a sell-side Equity Research capacity. What are the chances of being able to do this? If material, what steps should I take in accomplishing this? Moreover, I do have buy-side credit/CLO internship experience.
Happy to chat in PMs if that works as well. Thank you all!
Voluptatem blanditiis cupiditate nulla et. Cumque dolores rem nemo nostrum. Ad nemo accusamus atque iure illum. Doloribus sed ducimus ullam quisquam quia sunt.
Inventore explicabo illum dolorem adipisci. Ratione vel in sapiente dolorum cum asperiores est. Ducimus in accusantium dolor incidunt dolorem consequatur. Dolorem dolorem est natus ut consequuntur quo. Atque velit aut non omnis.
Quo possimus optio nisi minima voluptatem aperiam dolore. Molestiae excepturi dicta quis consectetur debitis. Praesentium mollitia adipisci asperiores neque iure asperiores cumque. Quia expedita saepe debitis mollitia id sit. Eaque debitis sint nam non et.
Repellendus et minima aut a pariatur excepturi quibusdam. Est delectus aut accusantium ipsam distinctio eligendi rerum. Est dicta sint officia exercitationem nostrum blanditiis sunt. Fugit non dolore qui voluptates ex. Enim numquam qui ut et rem eum. A autem aut dolor libero.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...